Doxorubicin | search
Click here to view Doxorubicin news from 60+ newspapers.
Bookmark or Share- Doxorubicin: Uses, Interactions, Mechanism of Action - DrugBank OnlineDoxorubicin is indicated for the treatment of neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin and non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumor, metastatic neuroblastoma, metastatic soft tissue and bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell ...
- A comprehensive review on time-tested anticancer drug doxorubicinDoxorubicin or Adriamycin, is one of the most widely used chemotherapeutic drug for treating a myriad of cancers. It induces cell death through multiple intracellular targets: reactive oxygen species generation, DNA-adduct formation, topoisomerase II inhibition, histone eviction, Ca 2+ and iron hemostasis regulation, and ceramide overproduction.
- Doxorubicin Hydrochloride - NCI - National Cancer InstituteDoxorubicin hydrochloride is approved to be used alone or with other drugs to treat: Acute lymphoblastic leukemia (ALL). Acute myeloid leukemia (AML). Breast cancer. It is used: After surgery to remove the primary tumor in women whose cancer has spread to the lymph nodes under the arm. It is used with other drugs. In patients with metastatic ...
- Doxorubicin: MedlinePlus Drug InformationDoxorubicin is used in combination with other medications to treat certain types of bladder, breast, lung, stomach, and ovarian cancer; Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that begins in the cells of the immune system); and certain types of leukemia (cancer of the white blood cells), including acute ...
- Doxorubicin Uses, Side Effects & Warnings - Drugs.comDoxorubicin is used to treat different types of cancers that affect the breast, bladder, kidneys, ovaries, thyroid, stomach, lungs, bones, nerve tissues, joints, and soft tissues. Doxorubicin is also used to treat Hodgkin lymphoma, non-Hodgkin lymphoma, and certain types of leukemia.
More
